Braiin Ltd (NASDAQ:BRAI) Short Interest Update

Braiin Ltd (NASDAQ:BRAI) was the target of a significant growth in short interest in the month of May. As of May 29th, there was short interest totaling 114,060 shares, a growth of 168.6% from the May 14th total of 42,469 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average daily volume of 1,156,130 shares, the short-interest ratio is currently 0.1 days.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on BRAI. Wall Street Zen raised Braiin from a “sell” rating to a “hold” rating in a report on Sunday, May 31st. Weiss Ratings began coverage on Braiin in a report on Wednesday, May 6th. They issued a “sell (e+)” rating on the stock. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.

Key Braiin News

Here are the key news stories impacting Braiin this week:

• Positive Sentiment: New research suggesting the brain may recover without a full night of sleep could support broader interest in brain health science and related innovation. The Brain May Not Need Full Sleep To Recover, New Research Finds
• Positive Sentiment: A study finding the brain can keep improving into the 90s may lift sentiment around cognitive health, aging, and neuroscience-focused companies. Your brain can keep improving into your 90s, study finds
• Positive Sentiment: Research on vitamin C and preserving gray matter volume adds to the positive backdrop for brain-health and longevity themes. Vitamin C may help preserve brain gray matter volume as we age
• Neutral Sentiment: A deep-learning model that parcellates the brain using only dMRI highlights progress in brain imaging AI, but the direct impact on Braiin Ltd is unclear. New Deep Learning Model Parcellates Brain Using Only dMRI
• Neutral Sentiment: Articles on migraines, obesity-related brain signaling, socioeconomic effects on brain development, and brain-cell computing are interesting scientifically, but they do not appear to materially affect Braiin’s near-term stock outlook. How Frequent Migraines Could Be Quietly Impacting Your Long-Term Brain Health CT researcher studies how the brain prepares the body for food. It could help in obesity treatment. Study highlights influence of socioeconomic status on children’s brain development Spark Notes: Inside the fascinating world of computers powered by brain cells
• Neutral Sentiment: Research into astrocytes and whether certain foods may protect against brain tumors adds to the general neuroscience news flow, but the market impact on Braiin Ltd remains limited. Your Brain’s ‘Dark Matter’ Could Rewrite What We Know About Your Consciousness, Behavior, and Decision-Making Do Indian foods protect against brain tumours? Neurosurgeon explains what your thali gets right

Braiin Stock Down 0.5%

Braiin stock traded down $0.04 during midday trading on Friday, hitting $7.64. 27,246 shares of the company were exchanged, compared to its average volume of 239,116. Braiin has a fifty-two week low of $4.19 and a fifty-two week high of $33.00. The stock’s fifty day simple moving average is $7.87.

About Braiin

Braiin Limited is an Australian technology company leveraging proprietary intellectual property and patented artificial intelligence/machine learning (“AI/ML”) technologies to deliver actionable insights across high-growth verticals: Agriculture, Property Technology, and Customer Experience as a Service (“CXaaS”). Our platforms are designed to address inefficiencies and drive data-backed decision-making across traditionally analog sectors. Our first commercial focus is on the agriculture technology sector, where we have successfully deployed our AI-powered solutions across multiple implementations.